The A-share innovative drug sector rebounded after hitting a low, with Yuhang Pharmaceutical hitting the daily limit. Previously, Huasen Pharmaceutical had also hit the daily limit, and other stocks such as ZJ Bio-tech, CSPC Pharmaceutical Innovation, Longshen Rongfa, Tailong Pharmaceutical, and WuXi AppTec followed suit.